Skip to main content
. 2016 Oct 17;101(11):4103–4109. doi: 10.1210/jc.2015-3989

Figure 4.

Figure 4.

Kaplan-Meier estimate of PFS of lenvatinib-treated patients with RR-DTC stratified by tumor size reduction (above vs below the median at wk 8, −24.7%).